Text Size: Small Text Medium Text Large Text
Contrast: Standard Contrast High Contrast

We Pursue Eye Research

What Our Studies Mean To You

Publications

Cataract and Intraocular Lens
  1. Richardson MR, Price MO, Price FW, Pardo JC, Grandin JC, You J, Wang M, Yoder MC. Proteomic analysis of human aqueous humor using multidimensional protein identification technology. Molecular Vision 2009;15:2740-50. http://www.molvis.org/molvis/v15/a289/
  2. Price MO, Price FW, Jr, Werner L, Berlie C, Mamalis N. Late dislocation of scleral-sutured posterior chamber intraocular lenses. Journal of Cataract & Refractive Surgery 2005; 31: 1321-1326. 
  3. Price MO, Quillin C, Price FW. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration.  Current Eye Research, 2005; 30:563-567. 
  4. Price. FW, Mackool RJ, Miller KM, Koch P, Oetting TA, Johnson T. US. Interim results of the United States investigational device study of the Ophtec capsular tension ring. Ophthalmology, 2005;112:460-465. 
  5. Price MO, Price FW, Chang DF, Kelley KA, Olsan MD, Miller KM. Ophtec iris reconstruction lens United States clinical trial phase I. Ophthalmology, 2004, III; 1874-1852. 
  6. Price MO, Price FW, Jr. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Current Medical Research & Opinion 2004; 20: 2015-2019. 
  7. Parker DS, Price FW. Suture fixation of a posterior chamber intraocular lens in anticoagulated patients. J Cataract Refract Surg, 2003; 29:949-954.
  8. Price FW, Dobbins K, Zeh WG. Penetration of topically administered ofloxacin and trimethoprim into aqueous humor. Journal of Ocular Pharmacology and Therapeutics 2002; 18(5):445-53. 
  9. Zeh WG, Price FW. Iris fixation of posterior chamber intraocular lenses. J Cataract Refract Surg, 2000; 26(7):1028-34. 
  10. Zeh WG, Price FW. Anesthetic and nonsteroidal agents in cataract surgery. Therapeutic Updates in Ophthalmology 1999; 2(3).
  11. Price FW, Parker DA. Horizontal corneal diameter and its implications for implanting sulcus-fixated lenses. 1997; 23(8):1131-2.
  12. Price FW, Wellemeyer ML. Transscleral fixation of posterior chamber intraocular lenses. J Cataract Refract Surg 1995;20:567-573. 
  13. Lee DA, Price FW, Whitson, WE. Intraocular complications associated with the Dubroff anterior chamber lens. J Cataract Refract Surg 1994;20:421-425. 
  14. Tilden ME, Price FW. Management of coincident corneal diseases and cataracts. Cur Opin Ophthalmol 1994,5;1:93-100.
  15. Lee DA, Price FW. Management of concurrent corneal diseases and cataract. Cur Opin Ophthalmol 1993,4;1:97-101.
  16. Coli AF, Price FW, Whitson WE. Intraocular lens exchange for anterior chamber intraocular lens-induced corneal endothelial damage. Ophthalmology 1993;100:384-393. 
  17. Price FW, Whitson WE, Collins KS, Johns SK. Changing trends in explanted intraocular lenses: a single center study. J Cataract Refract Surg 1992;18:470-474. 
  18. Price FW, Whitson WE, Collins KS, Johns SK. Explantation of posterior chamber lenses. J Cataract Refract Surg 1992;18:475-479. 
  19. Price FW, Whitson WE. Suprachoroidal hemorrhage after placement of a scleral-fixated lens. J Cataract Refract Surg 1990;16(4):514-515. 
  20. Mamalis N, Craig MT, Price FW. Spectrum of Nd:YAG laser-induced intraocular lens damage in explanted lenses. J Cataract Refract Surg 1990;16:495-500.
  21. Price FW, Whitson WE. Natural history of cystoid macular edema in pseudophakic bullous keratopathy. J Cataract Refract Surg 1990;16(2):163-169.
  22. Price, FW, Whitson, WE. Visual results of suture-fixated posterior chamber lenses during penetrating keratoplasty. Ophthalmology 96;8:1234-1240, 1989.
  23. Apple DJ, Price FW, Gwin RT, Imkamp E, Daun M, Casanova R, Hansen S, Carlson AN. Sutured retropupillary posterior chamber intraocular lenses for exchange or secondary implantation. The 12th annual Binkhorst lecture, 1988. Ophthalmology 1989;96:1241-1247. 
  24. Price, FW. A controlled method of removing the Stableflex lens. J Cataract Refract Surg 14:81-83,1988.
  25. Price FW. Factors contributing to corneal decompensation with the Stableflex lens. J Cataract Refract Surg 14:53-57,1988.
  26. Piest KL, Kincaid MC, Tetz MR, Apple DJ, Roberts WA, Price FW. Localized endophthalmitis: a newly described cause of the so-called toxic lens syndrome. J. Cataract Refract Surg 1987;13:498-510.
  27. Tetz MR, Apple DJ, Price FW, Piest KL, Kincaid MC, Bath, PE. A newly described complication of neodymium-YAG laser capsulotomy: exacerbation of an intraocular infection. Case report. Arch Ophthalmol 1987;105:1324-1325.
Glaucoma
  1. Vajaranant TS, Price MO, Price FW, Wilensky JT, Edward DP. Intraocular pressure measurements following Descemet stripping endothelial keratoplasty. Am J Ophthalmol 2008;145:780-6.
  2. Price FW, Price MO. Is it worthwhile to combine penetrating keratoplasty with glaucoma drainage implants? Cornea 2008; 27: 261-2.
  3. Vajaranant TS, Price MO, Price FW, Wilensky JT, Edward DP. Intraocular pressure measurements following Descemet stripping endothelial keratoplasty. Am J Ophthalmol 2008;145:780-6.
  4. Price, FW, Ziemba, SL. Placement of a collagen glaucoma drainage device to control intraocular pressure and chronic iritis secondary to juvenile rheumatoid arthritis. Ophthalmic Surgery and Lasers 2002; 33(3):233-36.
  5. Price FW, Zeh WG. Viscoelastic material as an adjunct to dissections and to treat microperforations during nonpenetrating filtering surgery. J Cataract Refract Surg, 2001; 27:639-641. 
  6. Price FW, Wellemeyer ML. Long-term results of Molteno implants. Ophthalmic Surg 1995;26(2):1-6. 
  7. Wellemeyer ML, Price FW. Molteno implants in patients with previous cyclocryotherapy. Ophthalmic Surg 1993;24:395-398.
  8. Whitson WE, Price FW. Reducing hypotony after Molteno procedure. Ophthalmic Surg 1992;23(6):434.
  9. Price FW, Whitson WE. Polypropylene ligatures as a means of controlling intraocular pressure with Molteno implants. Ophthalmic Surgery 1989;20:781-783.
Refractive Surgery
  1. Letko E, Price MO, Price FW. Influence of original flap creation method on incidence of epithelial ingrowth after LASIK retreatment. J Refract Surg. 2009;25:1039-41.
  2. Price FW. Re: central toxic keratopathy: description of a syndrome in laser refractive surgery. American Journal of Ophthalmology, 2007; 144:331-2.
  3. Hainline BC, Price MO, Price FW, Choi DM. Central Flap Necrosis after LASIK.(reply) J Refract Surg 2007;23:741-2
  4. Hainline BC, Choi DM, Price MO, Price FW. Central flap necrosis after LASIK with microkeratome and femtosecond laser created flaps. Journal of Refractive Surgery,2007;23:233-242.
  5. Price FW. Pressure-induced interface keratitis: a late complication following LASIK. Cornea, 2005; 24(4):505; author reply 505. 
  6. Bowers PJ, Zeldes SS, Price FW, McManis CL, Price MO. Outcomes of laser in situ keratomileusis in a Refractive Surgery fellowship program. J Refractive Surgery, 2004;20:265-9. 
  7. Thompson RW, Choi DM, Price MO, Price FW. Noncontact optical coherence tomography for measurement of corneal flap and residual stromal bed thickness after laser in situ keratomileusis. J Refractive Surgery, 2003, 19:507-515.
  8. Choi DM, Thompson RW, Price FW. Incisional refractive surgery. Current Opinion in Ophthalmology 2002;13:237-241.
  9. Price FW, Price MO, Zeh WG, Dobbins K. Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebo-controlled trial. J of Refractive Surgery, 2002; 18( 2):140-4. 
  10. Price FW.  Topical corticosteroids after keratorefractive surgery. J Cataract Refract Surg, 2002; 28(8):1307.
  11. Price FW, Willes L, Ries J, Lyng A, Price M. A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis. Ophthalmology, 2001;108(7):1236-44. 
  12. Price FW. “Lasik”. Focal Points; clinical modules for ophthalmologists, American Academy of Ophthalmology. 2000; XVIII (3).
  13. Price FW, Koller DL, Price MO. Central corneal pachymetry in patients undergoing laser in situ keratomileusis. Ophthalmology 1999; 106(11):2216-2220. 
  14. Price FW, Belin MW, Nordan LT, McDonnell PJ, Pop M. Epithelial haze, punctate keratopathy, and induced hyperopia after photorefractive keratectomy for myopia. J Refract Surg, 1999; 15(3):384-7. 
  15. Faktorovich EG, Maloney RK, Price FW, ARC-T Study Group. Effect of astigmatic keratotomy on spherical equivalent: results of the Astigmatism Reduction Clinical Trial. American Journal of Ophthalmology March 1999;127(3):260-9. 
  16. Riddle HK, Parker DAS, Price FW. Management of postkeratoplasty astigmatism. Current Opinion in Ophthalmology 1998;9(IV):15-28.
  17. Whitson WE, Price FW, Chang KC, Procope JA. Automated lamellar keratoplasty. Cornea Vol 3, Chap 172;1996:2165-2179.
  18. Steinert RF, Storie B, Smith P, McDonald MB, van Rij G, Bores LD, Colin JP, Durrie DS, Kelley C, Price FW, Rostron C, Waring III GO, Nordan LT. Hydrogel intracorneal lenses in aphakic eyes. Arch Ophthalmol 1996:114:135-141.
  19. Price FW, Whitson WE, Gonzales JS, Gonzales CR, Smith J. Automated lamellar keratomileusis in situ for myopia. J Refract Surg 1996;12:29-35.
  20. Price FW. Central islands of corneal steepening after automated lamellar keratoplasty for myopia. J Refract Surg 1996;12:36-41. 
  21. Price FW, Grene RB, Marks RG, Gonzales J, Arc-T Study Group. Arcuate transverse keratotomy for astigmatism followed by subsequent radial or transverse keratotomy. ARC-T Study Group. Astigmatism Reduction Clinical Trial. J Refract Surg 1996;12:68-76.
  22. Price FW, Grene RB, Marks RG, Gonzalas JS. Astigmatism reduction clinical trial: a multicenter prospective evaluation of the predictability of arcuate keratotomy. Evaluation of surgical nomogram predictability. ARC-T Study Group.Arch Ophthalmol 1995;113:277-282.
  23. Smith JA, Price FW. ALK; high hopes for high myopes. Review of Optometry, 1994;77-83.
  24. Price FW. Keratomileusis. In: Nordan LT, Maxwell WA, Davison JA. (eds) The Surgical Rehabilitation of Vision “An integrated approach to anterior segment surgery” New York, NY, Gower Medical Publishing 1992.
  25. Price FW. Keratomileusis. In: Stamper RL, Thompson KP, Waring GO. (eds) Ophthalmology Clinics of N.A.“Contemporary refractive surgery” Philadelphia, PA, W.B. Saunders 1992, 5(4):673-681.
  26. Price FW, Whitson WE. The art of surgical correction for postkeratoplasty astigmatism. In: International Ophthalmology Clinics Smolin G, Friedlaender MH, eds. Refract Surg Boston, Little, Brown & Co., 1991; 31:59-67.

Cornea Conditions and Surgery
  1. Price MO, Gorovoy M, Benetz BA, Price FW Jr, Menegay HJ, Debanne SM, Lass JH. Descemet’s Stripping Automated Endothelial Keratoplasty Outcomes Compared with Penetrating Keratoplasty from the Cornea Donor Study. Ophthalmology. 2009 Dec 22. [Epub ahead of print]
  2. Price MO, Giebel AW, Fairchild KM, Price FW. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology 2009;116:2361–2368. 
  3. McCauley MB, Price FW, Price MO. Descemet membrane automated endothelial keratoplasty: hybrid technique combining DSAEK stability with DMEK visual results. J Cataract Refract Surg 2009;35:1659-64.
  4. Vajaranant TS, Price MO, Price FW, Gao W, Wilensky JT, Edward DP. Visual acuity and intraocular pressure after Descemet’s stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Ophthalmology 2009;116:1644-50.
  5. Price FW, Price DA, Ngakeng V, Price MO. Survey of steroid usage patterns during and after low-risk penetrating keratoplasty. Cornea 2009;28:865-70.
  6. Sugar A, Tanner JP, Dontchev M, Tennant B, Schultze RL, Dunn SP, Lindquist TD, Gal RL, Beck RW, Kollman C, Mannis M, Holland E, for the Cornea Donor Study Investigator Group.  Recipient risk factors for graft failure in the cornea donor study.. Ophthalmology 2009; 116: 1023-1028.
  7. Dunn SP, Stark WJ, Stulting RD, Lass JH, Sugar A, Pavilack MA, Smith PW, Tanner JP, Dontchev M, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ; Cornea Donor Study Investigator Group. The effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection. Am J Ophthalmol. 2009;147:432-8.
  8. Price FW, Price MO, Grandin JC Kwon R. Deep anterior lamellar keratoplasty with femtosecond-laser zigzag incisions. Journal of Cataract and Refractive Surgery 2009;35:804-808.
  9. Price FW, Price MO. Does endothelial cell survival differ between DSEK and standard PK? Ophthalmology 2009;116:367-8.
  10. Price MO, Jordan CS, Moore G, Price FW. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmology 2009;93:391-5.
  11. Jordan CS, Price MO, Trespalacios R, Price FW. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br J Ophthalmol 2009;93:387-09. 
  12. Price FW, Price MO, Jordan CS. Safety of incomplete incision patterns in femtosecond laser-assisted penetrating keratoplasty. Journal of Cataract and Refractive Surgery 2008; 34:2099-2013.
  13. Price FW, Price MO. Femtosecond laser shaped penetrating keratoplasty: one-year results utilizing a top-hat configuration. Am J Ophthalmol 2008;145:210-214. 
  14. Price FW, Price, MO. Adult keratoplasty: has the prognosis improved in the last 25 years? Ophthalmology International, 2008; 28:141-146. 
  15. Ngakeng V, Hauck MJ, Price MO, Price FW. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications. Cornea 2008;27:905-910.
  16. Price MO, Price FW, Stoeger C, Soper M, Bavuso T, Locke G. Central thickness variation in precut DSAEK donor grafts. J Cataract and Refract Surg 2008;34:1423-4.
  17. Price MO, Baig KM, Brubaker JW, Price FW. Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty. Am J Ophthalmol 2008;146:36-41.
  18. Price FW. Precut tissue for descemet stripping automated endothelial keratoplasty. Cornea 2008; 27: 630-1.
  19. Cornea Donor Study Investigator Group. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology. 2008 Apr;115(4):627-632.e8. 
  20. Cornea Donor Study Investigator Group. The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology. 2008 Apr;115(4):620-626.e6. 
  21. Vajaranant TS, Price MO, Price FW, Wilensky JT, Edward DP. Intraocular pressure measurements following Descemet stripping endothelial keratoplasty. Am J Ophthalmol 2008;145:780-6.
  22. Price MO, Price FW. Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology. 2008;115:857-865. 
  23. Baig K, Price MO, Price FW. Descemet’s stripping with endothelial keratoplasty. US Ophthalmic Review 2007; 34-36.
  24. Price FW.  Using a “Small bubble technique” helps “big bubble technique”. British Journal of Ophthalmology, 2007; 91:1260-1  
  25. Allan B, Terry MA, Price FW, Price MO, Griffin N, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea 2007; 26:1039-42. 
  26. Price MO, Price FW. Descemet’s stripping endothelial keratoplasty. Current Opinion in Ophthalmology 2007; 18:290-4.
  27. Price MO, Price FW. Descemet stripping with endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Cornea 2007;26:493-497.
  28. Price MO, Price FW, Trespalacios R. Endothelial keratoplasty technique for aniridic aphakic eyes. J Cataract and Refract Surg 2007; 33:376-379. 
  29. Price MO, Price FW. Descemet stripping with endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Cornea 2007 May;26(4):493-7. 
  30. Romaniv N, Price MO, Price FW, Mamalis N. Donor descemet membrane detachment after endothelial keratoplasty. Cornea 2006:25: 943-947.
  31. Price FW, Price MO. A nonsurgical treatment for donor dislocation after descemet stripping endothelial keratoplasty (DSEK). Cornea 2006 Sep;25(8):991.
  32. Price FW, Price MO.  Descemet’s stripping and endothelial keratoplasty (DSEK).  In: Busin M, Arffa R. (eds) Atlas of microkeratome assisted lamellar keratoplasty Thorofare, NJ: Slack Inc.; 2009.
  33. Price MO, Price FW.  Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology 2006;113:1785-90. 
  34. Price MO, Price FW. Descemet’s stripping with endothelial keratoplasty: comparative outcomes with microkeratome-dissected and manually dissected donor tissue. Ophthalmology, 2006;113: 1936-1942. 
  35. Lord RK, Price FW, Price MO, Werner L, Mamalis N. Histology of posterior lamellar keratoplasty. Cornea 2006 Oct;25(9):1093-6.
  36. Price FW, Price MO. Endothelial keratoplasty to restore clarity to a failed penetrating graft. Cornea, 2006 Sep;25(8):895-9. 
  37. Price FW, Price MO. Descemet’s stripping with endothelial keratoplasty in 200 eyes: Early challenges and techniques to enhance donor adherence.  Journal of Cataract & Refractive Surgery, 2006;32:411-418.
  38. Price FW, Price MO. Descemet’s stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. Journal of Refractive Surgery, 2005; 21:339-345. 
  39. Price FW. Corneal transplantation as a refractive surgical procedure. Journal of Refractive Surgery, 2005;21:216-217. 
  40. Price FW. Fixed dilated pupil (Urrets-Zavalia syndrome) in corneal dystrophies. Cornea, 2005; 24(3):363.
  41. Price MO, Price FW, Jr, Maclellan D. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. Journal of Cataract & Refractive Surgery 2005,31:2137-41. 
  42. Riddle HK, Price MO, Price FW. Topical anesthesia for penetrating keratoplasty. Cornea, 2004; 23:712-714. 
  43. Price MO, Price FW. Cataract progression and treatment following posterior lamellar keratoplasty. J Cataract ad Refract Surg, 2004;30:1310-5. 
  44. Steinemann TL, Pinninti U, Szczotka LB, Eiferman RA, Price FW. Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors. Eye Contact Lens. 2003 Oct;29(4):196-200.
  45. Thompson RW, Price MO, Bowers PJ, Price FW. Long-term graft survival after penetrating keratoplasty. Ophthalmology, 2003; 121:1087-1092  
  46. Price MO, Thompson RW, Price FW. Risk factors for various causes of failure in initial corneal grafts. Archives of Ophthalmology, 2003; 121:1087-1092.
  47. Bowers P, Price MO, Zeldes S, Price FW. Superficial keratectomy with mitomycin-C for the treatment of Salzmann’s nodules. J Cataract and Refract Surg, 2003; 29(7):1302-6.
  48. Price FW. Does nonpenetrating glaucoma surgery reduce pain from filtration surgery? Therapeutic Updates in Ophthalmology 2002, Vol. 4, No. 4.
  49. Thompson RW, Choi DM, Price FW. Clear lens replacement surgery. International Ophthalmology Clinics 2002 42( 4):131-152.
  50. Price FW. Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata. Cornea, 2002; 21(7):733.
  51. McDonnell PJ, Price FW, Cantor LB, Donnenfeld ED, Pflugfelder SC, Solomon KD, “Nonsteroidal anti-inflammatory agents: They myths and truths roundtable”. Therapeutic Updates in Ophthamlology 2000; 2(4).
  52. Dobbins K, Price FW, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea 2000 19(6): 813-816.
  53. Price FW. New pieces for the puzzle: nonsteroidal anti-inflammatory drugs and corneal ulcers. Guest Editorial J Cataract Refract Surg. 2000; 26:1263-65
  54. Loden JC, Price FW Jr.  Price graft-over-host technique to manage positive pressure during penetrating keratoplasty.  J Cataract Refract Surg. 1998 Jun;24(6):736-8. 
  55. Riddle HK, Parker DAS, Price FW. Management of post keratoplasty astigmatism. Current Opinion in Ophthalmology 1998;9(IV):15-28.
  56. Price FW, Whitson WE, Gonzales JS, Johns SK. Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg 1997;23:898-902.
  57. Price FW, Whitson WE, Johns SK, Gonzales JS. Risk factors for corneal graft failure. J Refract Surg 1996;12:133-146. 
  58. Price FW, Hanna SI. Bilateral penetrating autokeratoplasty. J Refract Surg 1995;11:494-496.
  59. Price FW, Whitson WE, Collins KS, Gonzales JS. Corneal tissue levels of topically applied ciprofloxacin. Cornea 1995;14(2):152-156. 
  60. Price FW, Whitson WE, Ahad KA, Tavakkoli H. Suprachoroidal hemorrhage in penetrating keratoplasty. Ophthalmic Surg 1994;25(8):521-525. 
  61. Tilden ME, Price FW. Management of coincident corneal diseases and cataracts. Cur Opin Ophthalmol 1994,5;1:93-100.
  62. Lass JH, Musch DC, Gordon JF, Laing RA, Corneal Preservation Study Group. Epidermal growth factor and insulin use in corneal preservation: Results of a multi-center trial. Ophthalmology 1994;101:352-359.
  63. Lee DA, Price FW. Management of current corneal diseases and cataracts. Cur Opin Ophthalmol 1993,4;1:97-101.
  64. Price FW, Whitson WE, Collins KS. Five-year corneal graft survival. A large, single-center patient cohort. Arch Ophthalmol 1993;111:799-805.
  65. Whitcup SM, Nussenblatt RB, Price FW, Chan CC. Expression of cell adhesion molecules in corneal graft failure. Cornea 1993;12(6):475-480. 
  66. Coli AF, Price FW, Whitson WE. Intraocular lens exchange for anterior chamber intraocular lens-induced corneal endothelial damage. Ophthalmology 1993;100:384-393.
  67. Price FW. Penetrating keratoplasty for keratoconus. Bri J Ophthalmol 1992;6(1):61.
  68. Lopez JS, Price FW, Whitcup SM, Li Q, de Smet M, Chan CC. Immunohistochemistry of Terrien’s and Mooren’s corneal degeneration. Arch Ophthalmol 1991;109:988-992. 
  69. Price FW, Whitson WE, Marks RG. Progression of visual acuity after penetrating keratoplasty. Ophthalmology 1991;98:1177-1185.
  70. Price FW, Whitson WE. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991;98:322-328.
  71. Price FW, Whitson WE. The art of surgical correction for post keratoplasty astigmatism. In: International Ophthalmology Clinics Smolin G, Friedlaender MH, eds. Refract Surg Boston, Little, Brown & Co., 1991;vol 31,59-67.
  72. Price FW was a participant in Study Group for publication: Lass JH, Musch DC, Gordon JF. Epidermal growth factor and insulin in use in corneal preservation: study design and objectives of a multi-center trial. Refract and Corneal Surg 1990;6:92-98.
  73. Price FW, Whitson WE. Natural history of cystoid macular edema in pseudophakic bullous keratopathy. J Cataract Refract Surg 1990;16(2):163-169.
  74. Price FW. Air lamellar keratoplasty. Refract and Corneal Surg 1989;5:240-243. 
  75. Price, FW, Whitson, WE. Visual results of suture-fixated posterior chamber lenses during penetrating keratoplasty. Ophthalmology 1989; 96(8):1234-1240.
  76. Price FW. Factors contributing to corneal decompensation with the Stableflex lens. J Cataract Refract Surg 1988; 14:53-57.
  77. Price FW, Binder PS. Scarring of a recipient cornea following epikeratoplasty. Arch Ophthalmol 1987;105:1556-1560.